MLLT2 (4q21) -Courtesy Mariano Rocchi, Resources for Molecular Cytogenetics. Laboratories willing to validate the probes are welcome: contact rocchi@biologia.uniba.it.
DNA/RNA

Transcription
Alternate splicing in 5' → 10.5 and 12 kb; coding sequences: 3.6 kb.
Protein
Description NH2 -Nuclear Targeting Sequence -COOH 1210 amino acids; 140 kDa; contains many serine and proline rich sequences, a nuclear targeting sequence and a concensus sequence for ATP/GTP binding.
Expression
Widely expressed.
Localisation
Nuclear.
Function
Transcription activator.
Homology
LAF4.
Implicated in t(4;11)(q21;q23)/acute leukaemias → MLL/AF4
Disease Typically CD19+ B-ALL, biphenotypic AL, at times ANLL (M4/M5); may be congenital; treatment related leukaemia (secondary to epipodophyllotoxins). Prognosis Median survival < 1 yr. Cytogenetics Additional chromosome anomalies are found in ¼ of cases of which is the i(7q). Hybrid/Mutated Gene 5' MLL -3' AF4; 12 kb. Abnormal Protein 240 kDa protein with about 1400 amino acids from NH2 MLL and 850 from COOH AF4 (variable breakpoints); the reciprocal may or may not be expressed.
